Lead: Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables

Lead: Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables

Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables

American Journal of Public Health

Tobacco firms began acquiring US food companies in the 1960s-1990s to increase revenues and leverage research and development across holdings in tobacco, alcohol, and ultra-processed foods (UPF) subsidiaries. In this case study, the authors examine the development of Lunchables® following Phillip Morris (PMC) acquisition of Kraft and General Foods (KGF). PMC applied a “consumer-driven product development” strategy, previously used for tobacco, in the development process to maximize consumer appeal. PMC also used technologies from KGF to make lower-nicotine cigarettes and then low-fat versions of Lunchables®, in a “better-for-you” strategy to preserve market share in the face of health concerns about both products. The authors suggest public health strategies and policies used to address tobacco could be expanded to UPFs to reduce harm to children.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(100)

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction Cocaine use disorder (CUD) is an increasingly wi...

11 Elo 7min

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

2025 National Survey on Drug Use and Health (NSDUH) SAMHSA The 2025 National Survey on Drug Use and Health (NSDUH) shows encouraging trends among adolescents and young adults with broad declines acros...

4 Elo 7min

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study BMJ Open This retrospective cohort study usi...

28 Heinä 6min

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Trends in alcohol-related deaths in the United States over 55 years: 1968-2023 Alcohol, Clinical and Experimental Research  This study of alcohol-related mortality trends since 1968 used primarily dea...

21 Heinä 6min

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians  Journal of Substance Use and Addiction Treatment  Few patients with opioid use disorder (OUD) receive medications for ...

14 Heinä 7min

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial JAMA Network Open This randomized clinical trial of 340 adults with opio...

7 Heinä 7min

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week Journal of Studies on Alcohol and Drugs This study used a cause-specific...

30 Kesä 6min

Lead: Social media use trajectories and substance use experimentation: A prospective cohort study

Lead: Social media use trajectories and substance use experimentation: A prospective cohort study

Social media use trajectories and substance use experimentation: A prospective cohort study The American Journal of Psychiatry An analysis of data from more than 7,000 adolescents over 5 years found s...

23 Kesä 8min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
politiikan-puskaradio
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
otetaan-yhdet
rss-vaalirankkurit-podcast
rss-podme-livebox
rss-seksicast
tervo-halme
rikosmyytit
aihe
the-ulkopolitist
rss-bimbolia
rss-asiastudio
rss-vain-talouselamaa
rss-raha-talous-ja-politiikka
rss-merja-mahkan-rahat
et-sa-noin-voi-sanoo-esittaa
rss-50100-podcast